logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Modulation Of Protein Stability In Cancer Therapy 1st Edition Angelika M Burger

  • SKU: BELL-2163546
Modulation Of Protein Stability In Cancer Therapy 1st Edition Angelika M Burger
$ 31.00 $ 45.00 (-31%)

4.3

78 reviews

Modulation Of Protein Stability In Cancer Therapy 1st Edition Angelika M Burger instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 2 MB
Pages: 165
Author: Angelika M. Burger, Arun K. Seth (auth.), Eric Rubin, Kathleen Sakamoto (eds.)
ISBN: 9780387691435, 9780387691473, 038769143X, 0387691472
Language: English
Year: 2009
Edition: 1

Product desciption

Modulation Of Protein Stability In Cancer Therapy 1st Edition Angelika M Burger by Angelika M. Burger, Arun K. Seth (auth.), Eric Rubin, Kathleen Sakamoto (eds.) 9780387691435, 9780387691473, 038769143X, 0387691472 instant download after payment.

This book contains chapters written by experts in the field of the ubiquitin proteasome system and cancer. The authors have summarized current information on ubiquitin ligases and proteasomes as potential targets for cancer therapy. Topics covered in the book include an overview of ubiquitin ligases, deubiquitinating enzymes, and the proteasome. Specific diseases resulting from deregulated ubiquitin ligases, such as Von-Hippel-Lindau disease and Fanconi anemia are also discussed. Finally, novel approaches and drugs to target proteins involved in sumoylation, ubiquitination, and degradation are described.

Related Products